the Rawalpindi garrison city. The confirmation of hepatitis B in 128 individuals and hepatitis C in 536 individuals out of the 29,317 human blood samples collected for hepatitis diagnosis in the court union councils of Rawalpindi indicates a steady increase in the number of patients affected by the disease.
The Local Hepatitis Elimination and Prevention Programme (LHEAP), implemented under the US-based Global Task Force, is actively working on the diagnosis and treatment of hepatitis B and C. The programme aims to provide free treatment to patients.
As part of the programme, field staff visited 5,819 households and screened 29,317 individuals in four union councils (UCs) of Rawalpindi city, namely 10, 11, 14, and 15. The objective was to collect blood samples and provide treatment to 100,000 citizens. The results revealed that 128 individuals tested positive for hepatitis B, 536 individuals tested positive for hepatitis C, and 13 individuals were diagnosed with both hepatitis B and C.
To prevent the spread of the disease, a total of 12,462 individuals, including three pregnant women, have been vaccinated. Among those exposed to hepatitis B, 8,568 individuals received the first dose of vaccination, while 3,888 individuals received the second dose. Additionally, 175 individuals suffering from hepatitis C have been provided with medication for treatment.
Once the blood screening of 100,000 individuals is completed, a decision will be made regarding the initiation of the next project in Rawalpindi.
Comments
Post a Comment